🇺🇸 FDA
Patent

US 7968664

Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof

granted A61KA61K31/78A61P

Quick answer

US patent 7968664 (Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/78, A61P, A61P9/00, A61P9/10